Table 2.
Vascular factors and medication use in the ADAPT subpopulation.a
| Baseline measurements | Mean ± SD |
|---|---|
| SBP (mmHg) | 133.47 ± 11.65 |
| DBP (mmHg) | 75.30 ± 6.50 |
| Creatinine (mg/dL) | 0.95 ± 0.22 |
| Cholesterol (mg/dL) | 191.92 ± 39.34 |
| LDL (mg/dL) | 105.27 ± 34.07 |
| HDL (mg/dL) | 48.70 ± 12.51 |
| Medication use (yes) | Number (%) |
| Dihydropyridine | 18 (9) |
| Nondihydropyridine | 2 (1) |
| Angiotensin-converting enzyme inhibitor | 46 (23) |
| Angiotensin II receptor blockers | 21 (11) |
| Statin | 84 (43) |
| Placebo | 83 (42) |
| Celecoxib | 52 (26) |
| Naproxen | 62 (32) |
a
SBP and DBP were unavailable for one individual, and creatinine was unavailable for two individuals.Total cholesterol was available for 195 subjects, HDL was available for 102 subjects, and LDL was available for 100 subjects.